|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03803800 |
|
Date of registration:
|
09/01/2019 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis
MSCAR |
|
Scientific title:
|
Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis |
|
Date of first enrolment:
|
January 9, 2019 |
|
Target sample size:
|
31 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03803800 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Belgium
| | | | | | | |
|
Contacts
|
|
Name:
|
Bert O Eijnde |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hasselt |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
- Diagnosis Multiple Sclerosis.
- Healthy control.
- Aged >18y.
- Written informed consent.
Exclusion criteria:
- Contraindications to perform moderate to high intensity exercise.
- Participation in another study.
- Experienced acute MS related exacerbation <6 months prior to start of the study
- EDSS score > 6
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Multiple Sclerosis
|
|
Intervention(s)
|
|
Other: Classic, progressive endurance training
|
|
Other: Periodized exercise training
|
|
Dietary Supplement: beta-alanine
|
|
Primary Outcome(s)
|
|
Strength measurement
[Time Frame: 3 weeks]
|
|
Body mass index
[Time Frame: 3 weeks]
|
|
Body composition
[Time Frame: 3 weeks]
|
|
Muscle carnosine concentration
[Time Frame: 3 weeks]
|
|
Serum lactate
[Time Frame: 3 weeks]
|
|
Exercise capacity
[Time Frame: 3 weeks]
|
|
Secondary ID(s)
|
|
16.111/REVA16.14
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|